Recruiting nowPhase 1, Phase 2
Feasibility of Semaglutide in Advanced Lung Disease
Updated 2026-04-21 · NCT05746039See eligibility →
Sponsor
Active studies whose public registry record names University of Pennsylvania as lead sponsor.
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.